Search

Author/Creator Blissett, Robert S.

1. Cost-effectiveness of andexanet alfa versus four-factor prothrombin complex concentrate for the treatment of oral factor Xa inhibitor-related intracranial hemorrhage in the US. (31st December 2022)

Authors:
Fanikos, John; Goldstein, Joshua N.; Lovelace, Belinda; Beaubrun, Anne C.; Blissett, Robert S.; Aragão, Filipa
Journal:
Journal of medical economics
Issue:
Volume 25:Number 1(2022)
Page Start:
309
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. S660 Cost Effectiveness of Andexanet Alfa for Major Gastrointestinal Bleeding Associated With Factor Xa Inhibitors. (October 2021)

Authors:
Cash, Brooks D.; Goldstein, Joshua N.; Deitelzweig, Steven; Lovelace, Belinda; Christoph, Mary J.; Blissett, Robert S.; Fermann, Gregory J.
Journal:
American journal of gastroenterology
Issue:
Volume 116:Supplement(2021)ACG Annual Meeting Abstracts 1
Page Start:
S298
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗